ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 95 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $639,694 | -53.6% | 93,386 | -29.8% | 0.00% | -50.0% |
| Q2 2023 | $1,379,583 | +304.1% | 133,036 | +215.3% | 0.00% | +300.0% |
| Q1 2023 | $341,398 | +126.1% | 42,200 | -54.9% | 0.00% | 0.0% |
| Q2 2020 | $151,000 | +55.7% | 93,518 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | -96.0% | 93,518 | -92.8% | 0.00% | -87.5% |
| Q4 2019 | $2,449,000 | -39.3% | 1,295,966 | -65.3% | 0.01% | -46.7% |
| Q3 2019 | $4,034,000 | -10.5% | 3,734,793 | +81.5% | 0.02% | -6.2% |
| Q2 2019 | $4,507,000 | -36.5% | 2,057,936 | +73.6% | 0.02% | -40.7% |
| Q1 2019 | $7,101,000 | +44.2% | 1,185,528 | +77.9% | 0.03% | +22.7% |
| Q4 2018 | $4,925,000 | -15.8% | 666,430 | +65.5% | 0.02% | +4.8% |
| Q3 2018 | $5,846,000 | +260.6% | 402,624 | +396.1% | 0.02% | +200.0% |
| Q2 2018 | $1,621,000 | – | 81,166 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |